首页 > 最新文献

Iranian Journal of Pathology最新文献

英文 中文
Diagnostic Significance of Cytokeratin 20 and p53 as Adjunct Immunocytological Markers in Urine Cytology to Detect Urothelial Carcinomas: A Systematic Review Study. 细胞角蛋白20和p53作为尿细胞学辅助免疫细胞标记物检测尿路上皮癌的诊断意义:系统评价研究
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-07-16 DOI: 10.30699/IJP.2023.1972203.3004
Evelyn Angel

The progression and recurrence of urothelial carcinoma (UC) are correlated with carcinoma in situ and urothelial dysplasia. It is frequently challenging to distinguish dysplasia and carcinoma in situ from reactive atypia only based on histological characteristics. In daily practices, 2 of the adjunct immunohistochemistry markers (cytokeratin 20 (CK20) and p53) are used in addition to the histology to diagnose carcinoma in situ. This is accomplished by combining histological research results with immunohistochemistry. This systematic review summarizes the current findings on the diagnostic significance of p53 and CK20 as adjunct markers to urine cytology in the detection of UC. A systematic search of the relevant literature was conducted using PubMed, Wiley Online Library, and ScienceDirect databases. After screening for the eligibility criteria, a total of 14 selected articles were reviewed. Data extraction included a total number of samples, specimen samples, type of cells, and outcome parameters (mainly sensitivity and specificity). Urine cytology alone had a sensitivity of 75%-85% and specificity of 66%-95%. CK20 with urine cytology staining showed improved sensitivity and specificity in the range of 77%-94% and 71%-100%, respectively; p53 immunostaining with urine cytology showed a sensitivity of 52%-86% and specificity of 80%-98%. The dual staining in combination with urine cytology showed comparatively higher sensitivity and specificity in the range of 70%-90% and 74%-100%, respectively. This was more evident for high-grade UC (HGUC). Overall, single or dual staining combined with urine cytology was effective in this detection and can be applied as an adjunct marker in urine cytology.

尿路上皮癌(UC)的进展和复发与原位癌和尿路上皮发育不良有关。仅根据组织学特征来区分发育不良和原位癌与反应性非典型性通常是一项挑战。在日常实践中,除了组织学外,还使用2种辅助免疫组织化学标记物(细胞角蛋白20(CK20)和p53)来诊断原位癌。这是通过将组织学研究结果与免疫组织化学相结合来实现的。本系统综述了p53和CK20作为尿液细胞学辅助标志物在UC检测中的诊断意义。使用PubMed、Wiley Online Library和ScienceDirect数据库对相关文献进行了系统检索。在筛选合格标准后,共对14篇选定的文章进行了审查。数据提取包括样本总数、样本样本、细胞类型和结果参数(主要是敏感性和特异性)。单用尿液细胞学检查的敏感性为75%-85%,特异性为66%-95%。CK20尿细胞学染色显示敏感性和特异性分别提高了77%-94%和71%-100%;尿细胞学检测p53的敏感性为52%~86%,特异性为80%~98%。双重染色结合尿液细胞学检查显示出相对较高的敏感性和特异性,分别在70%-90%和74%-100%之间。这在高级别UC(HGUC)中更为明显。总的来说,单染色或双染色结合尿液细胞学在这种检测中是有效的,可以作为尿液细胞学的辅助标志物
{"title":"Diagnostic Significance of Cytokeratin 20 and p53 as Adjunct Immunocytological Markers in Urine Cytology to Detect Urothelial Carcinomas: A Systematic Review Study.","authors":"Evelyn Angel","doi":"10.30699/IJP.2023.1972203.3004","DOIUrl":"10.30699/IJP.2023.1972203.3004","url":null,"abstract":"<p><p>The progression and recurrence of urothelial carcinoma (UC) are correlated with carcinoma <i>in situ</i> and urothelial dysplasia. It is frequently challenging to distinguish dysplasia and carcinoma <i>in situ</i> from reactive atypia only based on histological characteristics. In daily practices, 2 of the adjunct immunohistochemistry markers (cytokeratin 20 (CK20) and p53) are used in addition to the histology to diagnose carcinoma <i>in situ</i>. This is accomplished by combining histological research results with immunohistochemistry. This systematic review summarizes the current findings on the diagnostic significance of p53 and CK20 as adjunct markers to urine cytology in the detection of UC. A systematic search of the relevant literature was conducted using PubMed, Wiley Online Library, and ScienceDirect databases. After screening for the eligibility criteria, a total of 14 selected articles were reviewed. Data extraction included a total number of samples, specimen samples, type of cells, and outcome parameters (mainly sensitivity and specificity). Urine cytology alone had a sensitivity of 75%-85% and specificity of 66%-95%. CK20 with urine cytology staining showed improved sensitivity and specificity in the range of 77%-94% and 71%-100%, respectively; p53 immunostaining with urine cytology showed a sensitivity of 52%-86% and specificity of 80%-98%. The dual staining in combination with urine cytology showed comparatively higher sensitivity and specificity in the range of 70%-90% and 74%-100%, respectively. This was more evident for high-grade UC (HGUC). Overall, single or dual staining combined with urine cytology was effective in this detection and can be applied as an adjunct marker in urine cytology.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":" ","pages":"257-269"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47616236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the Milan System for Reporting Salivary Gland Cytology: A Prospective Study. 应用米兰系统报告唾液腺细胞学:一项前瞻性研究。
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-10-15 DOI: 10.30699/IJP.2023.199632.3098
Reema Bhushan, Jyoti Priyadarshini Shrivastava, Varsha Verma

Background & objective: The Milan system of classification of the salivary gland lesions came up with an aim to establish a universal reporting protocol. The aim of this study was to classify the fine-needle aspiration cytology (FNAC) cases of salivary gland according to the Milan system.

Methods: All the cases presenting with salivary gland lesion for FNAC were considered. The clinical data was recorded. Cytology findings were analyzed according to the Milan System. Histopathological correlation was made wherever available.

Results: A total of 100 cases of salivary gland lesions were collected and categorized according to the Milan system. They were correlated with histopathology in 45 cases. The patients' age varied from 2-85 years. Parotid gland was the most commonly affected. Category 1 (non-diagnostic) comprised of three cases. Category 2 (non-neoplastic) had 40 cases. In category 4a (benign) there were 43 cases, and the most common lesion was pleomorphic adenoma. Category 5 (suspicious of malignancy) comprised of 3 cases. Category 6 (malignant) comprised of 11 cases and the most common lesion was mucoepidermoid carcinoma. In category 2, the cytological findings of 5 cases were concordant with histopathology while, 2 were discordant. In category 4a (benign), 20 cases were concordant, and 3 cases were discordant (2 cases were mucoepidermoid carcinoma, 1 was adenoid cystic carcinoma on histology). The risks of malignancy in NN, AUS, benign, SOM, and malignant were 33.3, 2.5, 0, 7, 66.6, and 100%, respectively.

Conclusion: Milan system of reporting salivary gland cytopathology may have great potential of escalating clinical communication and may guide appropriate treatment.

背景与目的:唾液腺病变米兰分类系统提出的目的是建立一个通用的报告协议。本研究的目的是根据米兰系统对涎腺细针穿刺细胞学(FNAC)病例进行分类。方法:对所有出现涎腺病变的FNAC患者进行分析。记录临床资料。细胞学结果根据米兰系统进行分析。只要有组织病理学相关性。结果:共收集唾液腺病变100例,按Milan系统分类。其中45例与组织病理学相关。患者年龄2 ~ 85岁。腮腺是最常见的。第1类(非诊断性)包括3例。2类(非肿瘤性)40例。4a型(良性)43例,以多形性腺瘤最为常见。第五类(怀疑恶性肿瘤)3例。6类(恶性)11例,以黏液表皮样癌最为常见。在第2类中,细胞学结果与组织病理学一致的有5例,不一致的有2例。4a型(良性)一致20例,不一致3例(组织学上为粘液表皮样癌2例,腺样囊性癌1例)。NN、AUS、良性、SOM、恶性的风险分别为33.3、2.5、0、7、66.6和100%。结论:唾液腺细胞病理学米兰报告系统具有提升临床交流和指导合理治疗的潜力。
{"title":"Application of the Milan System for Reporting Salivary Gland Cytology: A Prospective Study.","authors":"Reema Bhushan, Jyoti Priyadarshini Shrivastava, Varsha Verma","doi":"10.30699/IJP.2023.199632.3098","DOIUrl":"https://doi.org/10.30699/IJP.2023.199632.3098","url":null,"abstract":"<p><strong>Background & objective: </strong>The Milan system of classification of the salivary gland lesions came up with an aim to establish a universal reporting protocol. The aim of this study was to classify the fine-needle aspiration cytology (FNAC) cases of salivary gland according to the Milan system.</p><p><strong>Methods: </strong>All the cases presenting with salivary gland lesion for FNAC were considered. The clinical data was recorded. Cytology findings were analyzed according to the Milan System. Histopathological correlation was made wherever available.</p><p><strong>Results: </strong>A total of 100 cases of salivary gland lesions were collected and categorized according to the Milan system. They were correlated with histopathology in 45 cases. The patients' age varied from 2-85 years. Parotid gland was the most commonly affected. Category 1 (non-diagnostic) comprised of three cases. Category 2 (non-neoplastic) had 40 cases. In category 4a (benign) there were 43 cases, and the most common lesion was pleomorphic adenoma. Category 5 (suspicious of malignancy) comprised of 3 cases. Category 6 (malignant) comprised of 11 cases and the most common lesion was mucoepidermoid carcinoma. In category 2, the cytological findings of 5 cases were concordant with histopathology while, 2 were discordant. In category 4a (benign), 20 cases were concordant, and 3 cases were discordant (2 cases were mucoepidermoid carcinoma, 1 was adenoid cystic carcinoma on histology). The risks of malignancy in NN, AUS, benign, SOM, and malignant were 33.3, 2.5, 0, 7, 66.6, and 100%, respectively.</p><p><strong>Conclusion: </strong>Milan system of reporting salivary gland cytopathology may have great potential of escalating clinical communication and may guide appropriate treatment.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 4","pages":"439-448"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138463202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rhinocerebral Mucormycosis Following COVID-19 Infection in Iran. 伊朗COVID-19感染后的鼻-脑毛霉菌病。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.545953.2845
Parisa Khorasani Esmaili, Shahriar Dabiri, Touraj Reza Mirshekari, Fatemmeh Nabi Pour, Ayeh Shamsadini, Hadi Eslami, Mohammadad Ali Damghani, Ali Asghar Arabi, Maryam Aamizadeh, Fatemeh Fani Maleki, Navid Gharaie, Shiva Pouradeli

Background & objective: Mucormycosis (also called black fungus) is an opportunistic serious fungal infection caused by mucormycetes. It can occur in diabetes mellitus patients and other immunosuppressive conditions with recent predisposing factors such as maxillofacial surgery and corticosteroid usage.

Methods: In this study, 14 patients were referred to the otorhinolaryngology or ophthalmology ward of Shafa Hospital (Kerman, Iran) with primary symptoms of nasal fullness and facial nerve dysfunction; they were admitted to the hospital to rule out the fungal infection. An endoscopic biopsy was taken from facial sinuses or orbit, and a microscopic evaluation was performed using hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining methods to rule out mucormycosis.

Results: In the histopathological examination, broad-based nonseptate branching fungal hyphae were found in nasal sinuses through the endoscopic biopsy. Most of the patients had diabetes mellitus with a primary symptom of facial nerve palsy; also, most of them received corticosteroids (intravenous [IV] or intramuscular [IM] injection). All patients have recently been infected with COVID-19 (less than 1 month ago).

Conclusion: COVID-19 infection might be a predisposing factor for many opportunistic infections, such as fungal elements); thus, the physician should be aware of the dosage and duration of corticosteroid therapy to prevent the development of these infections.

背景与目的:毛霉病(又称黑菌)是由毛霉菌引起的机会性严重真菌感染。它可发生在糖尿病患者和其他近期易患因素如颌面外科手术和皮质类固醇使用的免疫抑制患者。方法:在本研究中,14例患者转诊至伊朗沙法医院耳鼻咽喉或眼科病房,主要症状为鼻充盈和面神经功能障碍;他们被送进医院以排除真菌感染的可能性。从面部鼻窦或眼眶进行内镜活检,并使用苏木精和伊红(H&E)和周期性酸希夫(PAS)染色法进行显微镜评估,以排除毛霉病。结果:组织病理学检查中,内镜活检发现鼻窦内广泛无分隔的分枝真菌菌丝。糖尿病患者多以面神经麻痹为首发症状;此外,大多数患者接受了皮质类固醇(静脉注射[IV]或肌肉注射[IM])。所有患者最近都感染了COVID-19(不到1个月)。结论:COVID-19感染可能是多种机会性感染(如真菌因素)的易感因素;因此,医生应该了解皮质类固醇治疗的剂量和持续时间,以防止这些感染的发展。
{"title":"Rhinocerebral Mucormycosis Following COVID-19 Infection in Iran.","authors":"Parisa Khorasani Esmaili,&nbsp;Shahriar Dabiri,&nbsp;Touraj Reza Mirshekari,&nbsp;Fatemmeh Nabi Pour,&nbsp;Ayeh Shamsadini,&nbsp;Hadi Eslami,&nbsp;Mohammadad Ali Damghani,&nbsp;Ali Asghar Arabi,&nbsp;Maryam Aamizadeh,&nbsp;Fatemeh Fani Maleki,&nbsp;Navid Gharaie,&nbsp;Shiva Pouradeli","doi":"10.30699/IJP.2023.545953.2845","DOIUrl":"https://doi.org/10.30699/IJP.2023.545953.2845","url":null,"abstract":"<p><strong>Background & objective: </strong>Mucormycosis (also called black fungus) is an opportunistic serious fungal infection caused by mucormycetes. It can occur in diabetes mellitus patients and other immunosuppressive conditions with recent predisposing factors such as maxillofacial surgery and corticosteroid usage.</p><p><strong>Methods: </strong>In this study, 14 patients were referred to the otorhinolaryngology or ophthalmology ward of Shafa Hospital (Kerman, Iran) with primary symptoms of nasal fullness and facial nerve dysfunction; they were admitted to the hospital to rule out the fungal infection. An endoscopic biopsy was taken from facial sinuses or orbit, and a microscopic evaluation was performed using hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining methods to rule out mucormycosis.</p><p><strong>Results: </strong>In the histopathological examination, broad-based nonseptate branching fungal hyphae were found in nasal sinuses through the endoscopic biopsy. Most of the patients had diabetes mellitus with a primary symptom of facial nerve palsy; also, most of them received corticosteroids (intravenous [IV] or intramuscular [IM] injection). All patients have recently been infected with COVID-19 (less than 1 month ago).</p><p><strong>Conclusion: </strong>COVID-19 infection might be a predisposing factor for many opportunistic infections, such as fungal elements); thus, the physician should be aware of the dosage and duration of corticosteroid therapy to prevent the development of these infections.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 2","pages":"116-124"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10424255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers. GATA3和GCDFP15在三阴性乳腺癌中的表达
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.561917.2969
Mahsa Ahadi, Afshin Moradi, Elham Rabiee, Fatemeh Pourmotahari

Background & objective: Breast cancer is one of the most common cancers in the world. There are some different types of breast cancer and triple-negative breast cancer is the type in which no receptors for estrogen, progesterone, and human epidermal growth factor receptor-2 are expressed. Identifying factors that can facilitate the diagnosis of triple-negative breast cancer is important. In this study, we decided to investigate the expression of GATA3 and GCDFP15 genes in triple-negative breast cancers.

Methods: This is a retrospective descriptive-analytical study that was performed on 50 specimens of samples of triple-negative breast cancer. Data including age and sex, tumor grade, tumor size, types of invasion, GATA-3, and GCDFP-15 were assessed.

Results: The mean age of the patients was 48.3±14.17 years. Of the total specimens, 46% were positive for GCDFP15 and 90% were positive for GATA-3. The intensity of GATA3 was evaluated and it was observed that 33(73.3%) of the cells were strongly stained and 12(26.7%) were weakly stained. There were no relationships between GATA-3 and GCDFP-15 with tumor characteristics.

Conclusion: GATA-3 and GCDFP-15 may serve as diagnostic markers for triple-negative breast cancers and GATA-3 seems to be more reliable.

背景与目的:乳腺癌是世界上最常见的癌症之一。有一些不同类型的乳腺癌,三阴性乳腺癌是雌激素,孕激素和人类表皮生长因子受体-2的受体不表达的类型。确定有助于诊断三阴性乳腺癌的因素很重要。在本研究中,我们决定研究GATA3和GCDFP15基因在三阴性乳腺癌中的表达。方法:这是一项回顾性描述性分析研究,对50例三阴性乳腺癌样本进行了分析。评估数据包括年龄和性别、肿瘤分级、肿瘤大小、侵袭类型、GATA-3和GCDFP-15。结果:患者平均年龄48.3±14.17岁。GCDFP15阳性率为46%,GATA-3阳性率为90%。评价GATA3的表达强度,发现强染色细胞33个(73.3%),弱染色细胞12个(26.7%)。GATA-3和GCDFP-15与肿瘤特征无相关性。结论:GATA-3和GCDFP-15可作为三阴性乳腺癌的诊断标志物,GATA-3更可靠。
{"title":"Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers.","authors":"Mahsa Ahadi,&nbsp;Afshin Moradi,&nbsp;Elham Rabiee,&nbsp;Fatemeh Pourmotahari","doi":"10.30699/IJP.2023.561917.2969","DOIUrl":"https://doi.org/10.30699/IJP.2023.561917.2969","url":null,"abstract":"<p><strong>Background & objective: </strong>Breast cancer is one of the most common cancers in the world. There are some different types of breast cancer and triple-negative breast cancer is the type in which no receptors for estrogen, progesterone, and human epidermal growth factor receptor-2 are expressed. Identifying factors that can facilitate the diagnosis of triple-negative breast cancer is important. In this study, we decided to investigate the expression of GATA3 and GCDFP15 genes in triple-negative breast cancers.</p><p><strong>Methods: </strong>This is a retrospective descriptive-analytical study that was performed on 50 specimens of samples of triple-negative breast cancer. Data including age and sex, tumor grade, tumor size, types of invasion, GATA-3, and GCDFP-15 were assessed.</p><p><strong>Results: </strong>The mean age of the patients was 48.3±14.17 years. Of the total specimens, 46% were positive for GCDFP15 and 90% were positive for GATA-3. The intensity of GATA3 was evaluated and it was observed that 33(73.3%) of the cells were strongly stained and 12(26.7%) were weakly stained. There were no relationships between GATA-3 and GCDFP-15 with tumor characteristics.</p><p><strong>Conclusion: </strong>GATA-3 and GCDFP-15 may serve as diagnostic markers for triple-negative breast cancers and GATA-3 seems to be more reliable.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 1","pages":"90-95"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9736723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of Before and After Invasive Breast Cancer Neoadjuvant Chemotherapy for NFkB, Cyclin D1, and Survivin Expression. 浸润性乳腺癌新辅助化疗前后NFkB、Cyclin D1和Survivin表达的相关性
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijp.2023.562935.2983
Primariadewi Rustamadji, Elvan Wiyarta, Ineke Anggreani

Background & objective: Patients undergoing neoadjuvant chemotherapy (NC) for invasive breast cancer (IBC) therapy need biomarkers to track their progress. Because of the relationship between NFkB, Survivin, and Cyclin D1 with NC resistance, the different expression levels of each of these biomarkers can be different between pre- and post-NC in IBC. However, no research has examined the correlation between these biomarkers before and after the NC expression. This study aimed to determine the correlation among them.

Methods: Biomarkers expression (low and high) was used to classify 30 samples. ER, PR, HER2, Ki-67 status, tumor grade, age, and NC response were assessed. The amounts of Survivin, Cyclin D1, and NFkB were evaluated using immunohistochemistry, and the samples were classified based on the cut-off. Chi-square and linear regression were used to evaluate the data.

Results: No significant association was found with the changes in the expression of Survivin, Cyclin D1, and NFkB, both before and after the NC. Significant moderate correlations were shown between before and after the NC Survivin expression (r = 0.513) and Cyclin D1 expression (r = 0.543). The correlation between expression of NFkB before and after the NC was not significant.

Conclusion: The high potential of these proteins as prognostic indicators was demonstrated by the strong positive association between the expression of Survivin and Cyclin D1 before and after the NC. This upregulation of biomarkers indicates chemoresistance in developing IBC in the presence of NC.

背景与目的:浸润性乳腺癌(IBC)患者接受新辅助化疗(NC)治疗需要生物标志物来跟踪其进展。由于NFkB、Survivin和Cyclin D1与NC耐药之间的关系,这些生物标志物的不同表达水平在IBC NC前和NC后可能不同。然而,没有研究检测这些生物标志物在NC表达前后的相关性。本研究旨在确定两者之间的相关性。方法:采用生物标志物表达(低、高)对30份样本进行分类。评估ER、PR、HER2、Ki-67状态、肿瘤分级、年龄和NC反应。使用免疫组织化学方法评估Survivin、Cyclin D1和NFkB的含量,并根据截止值对样本进行分类。采用卡方回归和线性回归对数据进行评价。结果:NC前后Survivin、Cyclin D1、NFkB的表达变化无明显相关性。NC前后Survivin表达(r = 0.513)与Cyclin D1表达(r = 0.543)呈显著的中度相关。NC前后NFkB表达的相关性无统计学意义。结论:NC前后Survivin和Cyclin D1的表达呈显著正相关,证明了这些蛋白作为预后指标的高潜力。这种生物标志物的上调表明,在NC存在的情况下,IBC发生了化学耐药。
{"title":"Correlation of Before and After Invasive Breast Cancer Neoadjuvant Chemotherapy for NFkB, Cyclin D1, and Survivin Expression.","authors":"Primariadewi Rustamadji,&nbsp;Elvan Wiyarta,&nbsp;Ineke Anggreani","doi":"10.30699/ijp.2023.562935.2983","DOIUrl":"https://doi.org/10.30699/ijp.2023.562935.2983","url":null,"abstract":"<p><strong>Background & objective: </strong>Patients undergoing neoadjuvant chemotherapy (NC) for invasive breast cancer (IBC) therapy need biomarkers to track their progress. Because of the relationship between NFkB, Survivin, and Cyclin D1 with NC resistance, the different expression levels of each of these biomarkers can be different between pre- and post-NC in IBC. However, no research has examined the correlation between these biomarkers before and after the NC expression. This study aimed to determine the correlation among them.</p><p><strong>Methods: </strong>Biomarkers expression (low and high) was used to classify 30 samples. ER, PR, HER2, Ki-67 status, tumor grade, age, and NC response were assessed. The amounts of Survivin, Cyclin D1, and NFkB were evaluated using immunohistochemistry, and the samples were classified based on the cut-off. Chi-square and linear regression were used to evaluate the data.</p><p><strong>Results: </strong>No significant association was found with the changes in the expression of Survivin, Cyclin D1, and NFkB, both before and after the NC. Significant moderate correlations were shown between before and after the NC Survivin expression (r = 0.513) and Cyclin D1 expression (r = 0.543). The correlation between expression of NFkB before and after the NC was not significant.</p><p><strong>Conclusion: </strong>The high potential of these proteins as prognostic indicators was demonstrated by the strong positive association between the expression of Survivin and Cyclin D1 before and after the NC. This upregulation of biomarkers indicates chemoresistance in developing IBC in the presence of NC.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 2","pages":"147-155"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10048577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of HER2 Expression, MMR Deficiency, and PI3KCA Mutation in Pretreated Surgical Specimens of Patients with Esophageal Squamous Cell Carcinoma in Iran Cancer Institute. 伊朗癌症研究所食管鳞状细胞癌术前标本中HER2表达频率、MMR缺失和PI3KCA突变
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.563358.2989
Samaneh Salarvand Farzaneh Bagheri, Mahsa Gholizadeh, Sima Sharifi, Pooneh Panahi, Ebrahim Esmati, Marzieh Lashkari, Amirmohsen Jalaeefar, Mohammad Shirkhoda, Reza Shahsiah, Reza Ghalehtaki

Background & objective: Iran is located in the esophageal cancer geographical belt. As multiple genetic alterations are responsible for the molecular pathogenesis of esophageal squamous cell cancer (ESCC), the role and frequency of HER2 expression, MMR deficiency, and PI3KCA mutation are not well defined.

Methods: We carried out HER2/neu expression, dMMR/MSI high, and PI3KCA mutation analysis in specimens of patients with ESCC. We accessed archival tissue blocks related to specimens of 68 ESCC cases at the time of surgery following neoadjuvant chemoradiation. These patients underwent surgery during 2013-2018 at the Cancer Institute of Iran affiliated with the Tehran University of Medical Sciences in Tehran.

Results: None of the patients showed HER2 expression, dMMR/MSI high, or PI3K mutations.

Conclusion: dMMR/MSI-H and PI3KCA mutation and HER2 expression may not be reliable andfrequent targets for systemic therapy in patients with esophageal SCC.

背景与目的:伊朗地处食管癌地理带。由于多种遗传改变是食管鳞状细胞癌(ESCC)的分子发病机制,HER2表达、MMR缺陷和PI3KCA突变的作用和频率尚不明确。方法:对ESCC患者标本进行HER2/neu表达、dMMR/MSI高、PI3KCA突变分析。我们获取了68例ESCC病例在新辅助放化疗后手术时相关的档案组织块。这些患者于2013-2018年在德黑兰医学大学附属的伊朗癌症研究所接受了手术。结果:所有患者均未出现HER2表达、dMMR/MSI高或PI3K突变。结论:dMMR/MSI-H和PI3KCA突变和HER2表达可能不是食管鳞状细胞癌患者全身治疗的可靠和常见靶点。
{"title":"Frequency of HER2 Expression, MMR Deficiency, and PI3KCA Mutation in Pretreated Surgical Specimens of Patients with Esophageal Squamous Cell Carcinoma in Iran Cancer Institute.","authors":"Samaneh Salarvand Farzaneh Bagheri,&nbsp;Mahsa Gholizadeh,&nbsp;Sima Sharifi,&nbsp;Pooneh Panahi,&nbsp;Ebrahim Esmati,&nbsp;Marzieh Lashkari,&nbsp;Amirmohsen Jalaeefar,&nbsp;Mohammad Shirkhoda,&nbsp;Reza Shahsiah,&nbsp;Reza Ghalehtaki","doi":"10.30699/IJP.2023.563358.2989","DOIUrl":"https://doi.org/10.30699/IJP.2023.563358.2989","url":null,"abstract":"<p><strong>Background & objective: </strong>Iran is located in the esophageal cancer geographical belt. As multiple genetic alterations are responsible for the molecular pathogenesis of esophageal squamous cell cancer (ESCC), the role and frequency of <i>HER2</i> expression, <i>MMR</i> deficiency, and <i>PI3KCA</i> mutation are not well defined.</p><p><strong>Methods: </strong>We carried out <i>HER2/neu</i> expression, <i>dMMR/MSI</i> high, and <i>PI3KCA</i> mutation analysis in specimens of patients with ESCC. We accessed archival tissue blocks related to specimens of 68 ESCC cases at the time of surgery following neoadjuvant chemoradiation. These patients underwent surgery during 2013-2018 at the Cancer Institute of Iran affiliated with the Tehran University of Medical Sciences in Tehran.</p><p><strong>Results: </strong>None of the patients showed <i>HER2</i> expression, <i>dMMR/MSI</i> high, or <i>PI3K</i> mutations.</p><p><strong>Conclusion: </strong><i>dMMR/MSI-H</i> and <i>PI3KCA</i> mutation and <i>HER2</i> expression may not be reliable andfrequent targets for systemic therapy in patients with esophageal SCC.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 1","pages":"96-103"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10095939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
YAP1 and P53 Expression in Papillary Thyroid Carcinoma. 甲状腺乳头状癌中YAP1和P53的表达。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.553716.2897
Dalia Nabil Abdelhafez, Maram Mustafa Ayoub, Samira A Mahmoud, Hala M El Hanbuli

Background & objective: One of the most prevalent endocrine system cancers is papillary thyroid carcinoma, with complicated predisposing factors and pathogenesis. YAP1 (Yes-associated protein 1) is a well-known oncogene; its activity is increased in a variety of human malignancies and has recently been paid great attention. The present study examines YAP1 and P53 immunohistochemical expression in papillary thyroid carcinoma and investigates the association of their expression with the available clinicopathological risk factors to assess their possible prognostic role.

Methods: The current study used paraffin blocks of 60 cases of papillary thyroid carcinoma, which were immunohistochemically assessed for YAP1 and p53 expression. The study examined the association of their expression with clinicopathological characteristics.

Results: YAP1 expression was observed in 70% of papillary thyroid carcinoma cases. A statistically significant relation was observed between YAP1 expression and tumor size, tumor stage, tumor focality, lymph node metastases, and extrathyroidal extension (P-values were =0.003, > 0.001, 0.037, 0.025, and 0.006), respectively. p53 expression was observed in 85% of papillary thyroid carcinoma cases. A statistically significant relation was observed between p53 expression and tumor size (P=0.001) and tumor stage (P>0.001). A statistically significant relation was noticed between YAP1 and P53 expression (P=0.009).

Conclusion: YAP1 expression was found to be associated with many high-risk clinicopathological characteristics in patients with papillary thyroid carcinoma and with p53 expression; thus, it seems that YAP1 may have a specific impact on the patient's outcome.

背景与目的:甲状腺乳头状癌是最常见的内分泌系统肿瘤之一,其易感因素和发病机制复杂。YAP1 (Yes-associated protein 1)是一个众所周知的致癌基因;它的活性在各种人类恶性肿瘤中增加,最近受到了极大的关注。本研究检测了YAP1和P53在甲状腺乳头状癌中的免疫组织化学表达,并研究了它们的表达与可用的临床病理危险因素的关系,以评估它们可能的预后作用。方法:本研究使用60例甲状腺乳头状癌石蜡切片,免疫组织化学检测YAP1和p53的表达。该研究检查了它们的表达与临床病理特征的关系。结果:YAP1在70%的甲状腺乳头状癌中表达。YAP1表达与肿瘤大小、肿瘤分期、肿瘤灶性、淋巴结转移、甲状腺外扩张有统计学意义(p值分别为=0.003、> 0.001、0.037、0.025、0.006)。85%的甲状腺乳头状癌有P53表达。p53表达与肿瘤大小(P=0.001)、肿瘤分期(P>0.001)有统计学意义。YAP1与P53表达有统计学意义(P=0.009)。结论:YAP1的表达与甲状腺乳头状癌患者的许多高危临床病理特征及p53的表达有关;因此,YAP1似乎对患者的预后有特定的影响。
{"title":"YAP1 and P53 Expression in Papillary Thyroid Carcinoma.","authors":"Dalia Nabil Abdelhafez,&nbsp;Maram Mustafa Ayoub,&nbsp;Samira A Mahmoud,&nbsp;Hala M El Hanbuli","doi":"10.30699/IJP.2023.553716.2897","DOIUrl":"https://doi.org/10.30699/IJP.2023.553716.2897","url":null,"abstract":"<p><strong>Background & objective: </strong>One of the most prevalent endocrine system cancers is papillary thyroid carcinoma, with complicated predisposing factors and pathogenesis. YAP1 (Yes-associated protein 1) is a well-known oncogene; its activity is increased in a variety of human malignancies and has recently been paid great attention. The present study examines YAP1 and P53 immunohistochemical expression in papillary thyroid carcinoma and investigates the association of their expression with the available clinicopathological risk factors to assess their possible prognostic role.</p><p><strong>Methods: </strong>The current study used paraffin blocks of 60 cases of papillary thyroid carcinoma, which were immunohistochemically assessed for YAP1 and p53 expression. The study examined the association of their expression with clinicopathological characteristics.</p><p><strong>Results: </strong>YAP1 expression was observed in 70% of papillary thyroid carcinoma cases. A statistically significant relation was observed between YAP1 expression and tumor size, tumor stage, tumor focality, lymph node metastases, and extrathyroidal extension (P-values were =0.003, > 0.001, 0.037, 0.025, and 0.006), respectively. p53 expression was observed in 85% of papillary thyroid carcinoma cases. A statistically significant relation was observed between p53 expression and tumor size (<i>P</i>=0.001) and tumor stage (<i>P</i>>0.001). A statistically significant relation was noticed between YAP1 and P53 expression (<i>P</i>=0.009).</p><p><strong>Conclusion: </strong>YAP1 expression was found to be associated with many high-risk clinicopathological characteristics in patients with papillary thyroid carcinoma and with p53 expression; thus, it seems that YAP1 may have a specific impact on the patient's outcome.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 1","pages":"49-56"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9791917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of INI1 Protein Expression Through IHC Study in Pediatric High-Grade Brain Tumors in South of Iran in 2008-2021. 通过IHC研究评估伊朗南部2008-2021年儿童高级别脑肿瘤中INI1蛋白表达。
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-07-15 DOI: 10.30699/IJP.2023.561858.297
Maryam Mohebbi, Mansoureh Shokripour, Maral Mokhtari

Background & objective: Brain tumors are the most frequent solid tumors in children. High-grade tumors are more challenging in diagnosis. Atypical teratoid rhabdoid tumor (ATRT) may be mistaken for other high-grade brain tumors. Molecular genetic analysis of ATRT has shown deletion and mutation in the hSNF5/INI1 gene in most of the cases. The INI1 protein expression can be helpful for the accurate diagnosis.

Methods: In this study, immunohistochemical staining (IHC) using INI1 antibody was performed to determine the possibility of ATRT misdiagnosis. Totally, 147 tumors including 6 ATRTs, 81 medulloblastomas, and 60 other CNS tumors were examined in children between 0 and 17 years old.

Results: No nuclear staining was found in the six ATRT cases, while most of other CNS tumors demonstrated nuclear staining. Five cases were previously diagnosed with medulloblastoma, primitive neuroectodermal tumor (PNET), and anaplastic oligodendroglioma, while the diagnoses were changed to ATRT based on the re-evaluation of the H&E slides and INI1 study. Additionally, two cases were recurrent tumors whose features were consistent with those of ATRT. The INI1 immunostaining was negative in these cases.

Conclusion: INI1 was very helpful in distinguishing ATRT from its mimickers in challenging cases. All known ATRT cases in this study were immunonegative for INI1. Thus, INI1 is recommended to be used in the initial IHC panel for the high-grade brain tumors, especially in children under the age of three years, so that they can benefit from intensified therapeutic regimens.

背景与目的:脑肿瘤是儿童最常见的实体瘤。高级别肿瘤的诊断更具挑战性。非典型畸胎样横纹肌样肿瘤(ATRT)可能被误认为是其他高级别脑肿瘤。ATRT的分子遗传学分析显示在大多数情况下hSNF5/INI1基因缺失和突变。INI1蛋白的表达有助于准确诊断。方法:应用INI1抗体进行免疫组化染色(IHC),以确定ATRT误诊的可能性。在0至17岁的儿童中,共检查了147例肿瘤,包括6例ATRT、81例髓母细胞瘤和60例其他中枢神经系统肿瘤。结果:6例ATRT患者均未发现核染色,而其他中枢神经系统肿瘤大多可见核染色。5例先前被诊断为髓母细胞瘤、原始神经外胚层肿瘤(PNET)和间变性少突胶质瘤,而根据对H&E幻灯片和INI1研究的重新评估,诊断改为ATRT。此外,2例为复发性肿瘤,其特征与ATRT一致。INI1免疫染色在这些病例中为阴性。结论:INI1有助于在具有挑战性的情况下区分ATRT及其拟态物。本研究中所有已知的ATRT病例均为INI1免疫阴性。因此,INI1被推荐用于高级脑肿瘤的初始IHC小组,特别是在三岁以下的儿童中,这样他们就可以从强化治疗方案中受益。
{"title":"Evaluation of INI1 Protein Expression Through IHC Study in Pediatric High-Grade Brain Tumors in South of Iran in 2008-2021.","authors":"Maryam Mohebbi, Mansoureh Shokripour, Maral Mokhtari","doi":"10.30699/IJP.2023.561858.297","DOIUrl":"10.30699/IJP.2023.561858.297","url":null,"abstract":"<p><strong>Background & objective: </strong>Brain tumors are the most frequent solid tumors in children. High-grade tumors are more challenging in diagnosis. Atypical teratoid rhabdoid tumor (ATRT) may be mistaken for other high-grade brain tumors. Molecular genetic analysis of ATRT has shown deletion and mutation in the <i>hSNF5/INI1</i> gene in most of the cases. The INI1 protein expression can be helpful for the accurate diagnosis.</p><p><strong>Methods: </strong>In this study, immunohistochemical staining (IHC) using INI1 antibody was performed to determine the possibility of ATRT misdiagnosis. Totally, 147 tumors including 6 ATRTs, 81 medulloblastomas, and 60 other CNS tumors were examined in children between 0 and 17 years old.</p><p><strong>Results: </strong>No nuclear staining was found in the six ATRT cases, while most of other CNS tumors demonstrated nuclear staining. Five cases were previously diagnosed with medulloblastoma, primitive neuroectodermal tumor (PNET), and anaplastic oligodendroglioma, while the diagnoses were changed to ATRT based on the re-evaluation of the H&E slides and INI1 study. Additionally, two cases were recurrent tumors whose features were consistent with those of ATRT. The INI1 immunostaining was negative in these cases.</p><p><strong>Conclusion: </strong>INI1 was very helpful in distinguishing ATRT from its mimickers in challenging cases. All known ATRT cases in this study were immunonegative for INI1. Thus, INI1 is recommended to be used in the initial IHC panel for the high-grade brain tumors, especially in children under the age of three years, so that they can benefit from intensified therapeutic regimens.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 3","pages":"279-288"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71522876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TERT Promoter Mutation in Benign and Malignant Salivary Gland Tumors; A Cross-Sectional Study. 良恶性唾液腺肿瘤TERT启动子突变的研究横断面研究。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.ijp.2023.556651.2927
Ali Zare-Mirzaie, Shamim Mollazadehghomi, Seyed Mohammad Heshmati, Amirhosein Mehrtash, Shabnam Mollazadehghomi

Background & objective: Telomere-related tumorigenesis mechanisms in the salivary gland, including mutation in the promoter region of TERT, have been rarely investigated. Therefore, the present study aimed to investigate the mutation in the promoter region of TERT in benign and malignant salivary gland tumors.

Methods: This was a descriptive-analytical cross-sectional study. Tissue samples of 54 patients with primary salivary gland tumors sent to the pathology department of Rasool-e-Akram Hospital from September 2017 to September 2021 were examined. Fifteen samples including two groups of the most common benign tumors (n=5; 3 pleomorphic adenomas and 2 Warthin tumors) and four groups of the most common malignant tumors (n=10; 3 mucoepidermoid carcinomas, 3 adenoid cystic carcinomas, 2 acinic cell carcinoma, and 2 salivary duct carcinoma) were selected. The promoter region of TERT, including well-known hot spot regions, is sequenced using the Sanger sequencing method. Data were analyzed using statistical software R version 4.1.2.

Results: Of 15 salivary gland tumor specimens, consisting of 5 benign tumors and 10 malignant tumors after DNA sequencing, TERT promoter region mutation was only seen in one of the adenoid cystic carcinoma samples, located at -146 bp upstream from ATG (chr5: 1,295,250 C>T).

Conclusion: TERT promoter mutation was not different in malignant and benign salivary tumors. Nonetheless, there are a few studies that report TERT promoter mutation in adenoid cystic carcinoma of the salivary gland, necessitating the need for further investigations.

背景与目的:唾液腺中端粒相关的肿瘤发生机制,包括TERT启动子区域的突变,很少被研究。因此,本研究旨在探讨TERT启动子区在良恶性唾液腺肿瘤中的突变情况。方法:这是一项描述性分析的横断面研究。对2017年9月至2021年9月在Rasool-e-Akram医院病理科室就诊的54例原发性唾液腺肿瘤患者的组织样本进行了检查。15个样本,包括两组最常见的良性肿瘤(n=5;多形性腺瘤3例,Warthin瘤2例)和4组最常见的恶性肿瘤(n=10;选择3例粘液表皮样癌、3例腺样囊性癌、2例腺泡细胞癌、2例唾液管癌。采用Sanger测序法对TERT的启动子区域,包括众所周知的热点区域进行测序。采用统计软件R 4.1.2对数据进行分析。结果:DNA测序后,在15例涎腺肿瘤标本中,5例为良性肿瘤,10例为恶性肿瘤,仅1例腺样囊性癌标本中发现TERT启动子区突变,位于ATG上游-146 bp (chr5: 1,295,250 C>T)。结论:TERT启动子突变在恶性和良性涎腺肿瘤中无明显差异。尽管如此,也有少数研究报道了唾液腺腺样囊性癌中TERT启动子突变,需要进一步的研究。
{"title":"TERT Promoter Mutation in Benign and Malignant Salivary Gland Tumors; A Cross-Sectional Study.","authors":"Ali Zare-Mirzaie,&nbsp;Shamim Mollazadehghomi,&nbsp;Seyed Mohammad Heshmati,&nbsp;Amirhosein Mehrtash,&nbsp;Shabnam Mollazadehghomi","doi":"10.30699/IJP.ijp.2023.556651.2927","DOIUrl":"https://doi.org/10.30699/IJP.ijp.2023.556651.2927","url":null,"abstract":"<p><strong>Background & objective: </strong>Telomere-related tumorigenesis mechanisms in the salivary gland, including mutation in the promoter region of TERT, have been rarely investigated. Therefore, the present study aimed to investigate the mutation in the promoter region of TERT in benign and malignant salivary gland tumors.</p><p><strong>Methods: </strong>This was a descriptive-analytical cross-sectional study. Tissue samples of 54 patients with primary salivary gland tumors sent to the pathology department of Rasool-e-Akram Hospital from September 2017 to September 2021 were examined. Fifteen samples including two groups of the most common benign tumors (n=5; 3 pleomorphic adenomas and 2 Warthin tumors) and four groups of the most common malignant tumors (n=10; 3 mucoepidermoid carcinomas, 3 adenoid cystic carcinomas, 2 acinic cell carcinoma, and 2 salivary duct carcinoma) were selected. The promoter region of TERT, including well-known hot spot regions, is sequenced using the Sanger sequencing method. Data were analyzed using statistical software R version 4.1.2.</p><p><strong>Results: </strong>Of 15 salivary gland tumor specimens, consisting of 5 benign tumors and 10 malignant tumors after DNA sequencing, TERT promoter region mutation was only seen in one of the adenoid cystic carcinoma samples, located at -146 bp upstream from ATG (chr5: 1,295,250 C>T).</p><p><strong>Conclusion: </strong>TERT promoter mutation was not different in malignant and benign salivary tumors. Nonetheless, there are a few studies that report TERT promoter mutation in adenoid cystic carcinoma of the salivary gland, necessitating the need for further investigations.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 1","pages":"64-74"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9736725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Placental Mesenchymal Dysplasia Associated with Severe Intrauterine Growth Restriction: A Case Report. 胎盘间充质发育不良伴严重宫内生长受限1例报告。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.548113.2828
Arshia Yazdani, Mohammad Ranaee, Sara Babazadeh, Fatemeh Shafizadeh

Placental mesenchymal dysplasia (PMD) is an uncommon placental lesion, which may mimic molar pregnancy at gross and microscopic examination. PMD can be associated with fetal growth restriction, Beckwith-Wiedemann syndrome, intrauterine fetal death, and preterm delivery. Nonetheless, it may also be associated with a normal appearing fetus. We aimed to emphasize that clinicians, radiologists, and pathologists should be aware of PMD as one of the etiologies of intrauterine growth restriction (IUGR). We presented the case of a 27-year-old gravida 1, para 1 woman who was admitted to Ayatollah Rouhani hospital, in Babol, Iran, at 30 weeks of gestation due to severe IUGR and fetal tachycardia. Ultrasound examination showed uteroplacental insufficiency and increased resistive index (RI) of umbilical artery. At last, a normal female fetus (1320 g) with no definitive anomalies was delivered by cesarean section. Pathological examination revealed cystically dilated stem villi with peripherally located thick-walled muscular stem vessels, and also stromal fibroblasts overgrowth in some stem villi. None of the examined sections revealed trophoblastic proliferation or stromal trophoblastic inclusion. The findings confirmed the diagnosis of PMD. Careful radiological and pathological examination should be performed in the case of IUGR for ruling out the rare placental abnormalities, including PMD.

胎盘间充质发育不良(PMD)是一种罕见的胎盘病变,肉眼和显微镜检查可能与磨牙妊娠相似。PMD可能与胎儿生长受限、贝克威氏综合征、宫内胎儿死亡和早产有关。尽管如此,它也可能与一个正常的胎儿有关。我们的目的是强调临床医生、放射科医生和病理学家应该意识到PMD是宫内生长受限(IUGR)的病因之一。我们报告了一名27岁的妊娠1期妇女的病例,她在妊娠30周时因严重的IUGR和胎儿心动过速被送入伊朗巴博勒的阿亚图拉鲁哈尼医院。超声检查显示子宫胎盘功能不全,脐动脉阻力指数增高。最后行剖宫产,产1例正常女胎(1320 g),无明显异常。病理检查显示干绒毛囊性扩张,周围有厚壁肌干血管,部分干绒毛间质成纤维细胞过度生长。未见滋养层增生或间质滋养层包涵。结果证实了PMD的诊断。在IUGR的情况下,应进行仔细的放射学和病理学检查,以排除罕见的胎盘异常,包括PMD。
{"title":"Placental Mesenchymal Dysplasia Associated with Severe Intrauterine Growth Restriction: A Case Report.","authors":"Arshia Yazdani,&nbsp;Mohammad Ranaee,&nbsp;Sara Babazadeh,&nbsp;Fatemeh Shafizadeh","doi":"10.30699/IJP.2023.548113.2828","DOIUrl":"https://doi.org/10.30699/IJP.2023.548113.2828","url":null,"abstract":"<p><p>Placental mesenchymal dysplasia (PMD) is an uncommon placental lesion, which may mimic molar pregnancy at gross and microscopic examination. PMD can be associated with fetal growth restriction, Beckwith-Wiedemann syndrome, intrauterine fetal death, and preterm delivery. Nonetheless, it may also be associated with a normal appearing fetus. We aimed to emphasize that clinicians, radiologists, and pathologists should be aware of PMD as one of the etiologies of intrauterine growth restriction (IUGR). We presented the case of a 27-year-old gravida 1, para 1 woman who was admitted to Ayatollah Rouhani hospital, in Babol, Iran, at 30 weeks of gestation due to severe IUGR and fetal tachycardia. Ultrasound examination showed uteroplacental insufficiency and increased resistive index (RI) of umbilical artery. At last, a normal female fetus (1320 g) with no definitive anomalies was delivered by cesarean section. Pathological examination revealed cystically dilated stem villi with peripherally located thick-walled muscular stem vessels, and also stromal fibroblasts overgrowth in some stem villi. None of the examined sections revealed trophoblastic proliferation or stromal trophoblastic inclusion. The findings confirmed the diagnosis of PMD. Careful radiological and pathological examination should be performed in the case of IUGR for ruling out the rare placental abnormalities, including PMD.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 2","pages":"221-224"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10039810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1